Various toxicities: 3 case reports

    This is a preview of subscription content, access via your institution.


    1. Kriulin I, et al. Secukinumab efficacy and safety in Juvenile Idiopathic Arthritis. Pediatric Rheumatology 18 (Suppl. 2): 73 abstr. P268, 2020. Available from: URL: [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Secukinumab. Reactions Weekly 1840, 333 (2021).

    Download citation